| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 88.1631 | 73 |
| GSM780708 | Untreated after 4 days (C2_1) | 89.6412 | 74 |
| GSM780709 | Untreated after 4 days (C3_1) | 78.0098 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 85.0935 | 73 |
| GSM780720 | Untreated after 4 days (C2_2) | 113.567 | 77 |
| GSM780721 | Untreated after 4 days (C3_2) | 85.1114 | 73 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 88.9959 | 73 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 80.8508 | 72 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 98.4905 | 75 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 97.2623 | 75 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 102.753 | 76 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 113.724 | 77 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 72.9696 | 70 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 80.0242 | 72 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 90.4817 | 74 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 68.659 | 69 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 96.2006 | 75 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 83.7494 | 72 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 123.937 | 78 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 91.3017 | 74 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 81.861 | 72 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 123.956 | 78 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 98.8045 | 75 |